Project Structure
.

Proteus is an EPSRC Interdisciplinary Research Collaboration (IRC), which is considered to be internationally-leading in the field of disruptive sensing healthcare systems and collaboration ethos.

Proteus was launched in October 2013 and consists of three collaborating institutions: the University of Edinburgh, Heriot Watt University and the University of Bath.

Our multidisciplinary team is delivering a transformative fibre-based point-of-care sensing device, which will lead to significant healthcare improvement through rapid point-of-care diagnosis, patient stratification and personalised drug therapy. The team is comprised of the Project Director, 12 Co-Investigators, 18 postdoctoral researchers, plus support staff (Project Manager, Clinical Project Manager, Engagement Strategist, Business Development Executive etc.). In addition there are over 20 PhD students associated with the project.

In order to break-down traditional barriers between the physical and biomedical and clinical sciences, and deliver major advances in healthcare, we are creating a new generation of physical scientists and engineers who have a translational agenda and mind-set. This has been facilitated by the setting up of an Interdisciplinary Hub, more details of which can be found here. This is the home for the core team of physical scientists, biomedical and clinical scientist and support staff.

The overall project structure is illustrated in the diagram below:

Management Structure

Proteus has developed a management structure that ensures maximum effectiveness in everything we deliver. The key members of the management team are Prof. Mark Bradley, Project Director; Dr Kev Dhaliwal, Clinical/Hub Lead, and Dr Anne Moore, Project Manager.

Oversight of the project is provided by an external Advisory Board, which meets every 6 months. The Advisory Board, together with the Project Director, reviews the overall plans to ensure we meet our key objectives. The combination of clinicians and industrialists on the advisory board means that they are able to make informed suggests on both potential commercialisation and exploitation strategies, and on clinical strategies. Details of the membership of the Advisory Board can be found here, and agendas for Advisory Board meetings can be found here.

The Steering Group was originally comprised of the IRC director, the project manager and the Co-Is. As the project has progressed, the meetings have expanded to include post-docs and, on alternative meetings, PhD students. The Steering Group meets every two months, focusing on the progress and scientific advances of both the individual work packages and the overall project. Updates from the clinical team are also presented so that the whole team remains up-to-date with the clinical work and goals of the project. It is a chance for all members of the team to see and review the breadth of work going on across the project, and there is plenty of time for discussions. Agendas for the Steering Group meetings can be found here.